Skip Navigation


Brain Advance Access originally published online on March 26, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
127/5/1200    most recent
awh146v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mitsikostas, D. D.
Right arrow Articles by Goadsby, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitsikostas, D. D.
Right arrow Articles by Goadsby, P. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 127, No. 5, 1200-1209, 2004
© 2004 Guarantors of Brain
doi: 10.1093/brain/awh146

A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth

Dimos D. Mitsikostas1,3, Petros P. Sfikakis2 and Peter J. Goadsby3

1 Athens Naval Hospital, Department of Neurology, Headache Clinic, 2 First Department of Propedeutic Medicine, Athens University Medical School, Laikon Hospital, Athens, Greece and 3 The National Hospital for Neurology and Neurosurgery, Institute of Neurology, Queen Square, London, UK

Correspondence to: Dimos D. Mitsikostas, MD, PhD, Athens Naval Hospital, Department of Neurology, 77A Vas. Sofias Avenue, 115 21 Athens, GreeceE-mail: dmitsikostas{at}ath.forthnet.gr

Controversies in the occurrence and implications of headache in patients suffering from systemic lupus erythematosus (SLE) triggered us to conduct an extensive literature search in order to answer five clinical questions. (i) Is headache prevalence higher in SLE patients than in the general population? (ii) Is ‘lupus headache’ a separate entity? (iii) Is there a distinct pathogenetic mechanism of headache in SLE? (iv) Is headache related to CNS involvement or general SLE activity? (v) Is headache related to anxiety- and depression-like symptoms in SLE? All published articles reporting data from >30 SLE patients were classified into four classes (I, IIa, IIb and III) by the quality of their evidence. We found no prospective controlled study (class I), but we identified seven controlled (class II) and 28 uncontrolled studies (class III) that retrospectively investigated the occurrence of headache in SLE patients. Eight out of 35 studies applied the International Headache Society (IHS) criteria for headache classification, whereas only four uncontrolled studies investigated paediatric SLE populations (class III). Pooled data from eight studies (controlled and uncontrolled) that used the IHS criteria show that 57.1% of SLE patients reported any type of headache (migraine 31.7% and tension-type headache 23.5%). Pooled data from seven controlled studies showed that the prevalence of all headache types, including migraine, was not different from controls. Insufficient evidence was found for the concept of ‘lupus headache’. No particular pathogenetic mechanism of headache in adult SLE patients has been identified, nor an association between headache and the disease status, including CNS involvement. There is no good evidence that headache is associated with anxiety and depression in SLE. Insufficient data (class III) do not allow safe conclusions for headache among paediatric SLE patients. These findings suggest that the occurrence of headache in adult SLE patients does not itself require further investigation and that headache in those patients should be classified according to IHS criteria and managed as primary headache if there is no specific indication of a role for SLE in the patient. These recommendations should be verified by a properly controlled and prospective study in both adult and paediatric populations.

Key Words: headache; migraine; systemic lupus erythematosus

Abbreviations: aCL= anticardiolipin antibody; IHS = International Headache Society; SLE = systemic lupus erythematosus; TTH = tension-type headache

Received November 14, 2003. Revised January 9, 2004. Accepted January 10, 2004.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BMJHome page
P. J Goadsby, J. Goldberg, and S. D Silberstein
Migraine in pregnancy
BMJ, June 28, 2008; 336(7659): 1502 - 1504.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, et al.
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
Ann Rheum Dis, February 1, 2008; 67(2): 195 - 205.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
S.M. Benseler and E.D. Silverman
Review: Neuropsychiatric involvement in pediatric systemic lupus erythematosus
Lupus, August 1, 2007; 16(8): 564 - 571.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
D. Kidd
The prevalence of headache in Behcet's syndrome
Rheumatology, May 1, 2006; 45(5): 621 - 623.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M.-T. Tseng, S.-C. Hsieh, C.-T. Shun, K.-L. Lee, C.-L. Pan, W.-M. Lin, Y.-H. Lin, C.-L. Yu, and S.-T. Hsieh
Skin denervation and cutaneous vasculitis in systemic lupus erythematosus
Brain, April 1, 2006; 129(4): 977 - 985.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.